Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M222Revenue $M0.1Net Margin (%)-52,307.0Altman Z-Score-1.4
Enterprise Value $M156EPS $-0.6Operating Margin %-55,180.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score238Pre-tax Margin (%)-52,306.0Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %-11.5Quick Ratio3.2Cash flow > EarningsY
Price/Sales2,2185-y EBITDA Growth Rate %5.9Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-69.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M55.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CYTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CYTRGeorge Soros 2014-06-30 Sold Out $2.92 - $5.31
($3.79)
$ 3.985%Sold Out0
CYTRGeorge Soros 2014-03-31 Buy $3.18 - $8.08
($5.96)
$ 3.98-33%New holding81,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CYTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CYTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patterson Scott Bradford10% Owner 2013-12-03Buy284,979$2.4463.11 view
Patterson Scott Bradford10% Owner 2013-11-07Buy50,000$2.0693.2 view
Patterson Scott Bradford10% Owner 2013-04-01Buy4,083$2.747.41 view
Patterson Scott Bradford10% Owner 2013-03-20Buy35,520$2.5854.26 view
Patterson Scott Bradford10% Owner 2013-03-20Buy3,980$2.6152.49 view
Patterson Scott Bradford10% Owner 2013-03-13Buy55,360$2.6749.06 view
Patterson Scott Bradford10% Owner 2012-10-22Buy180,000$2.5158.57 view
Patterson Scott Bradford10% Owner 2012-10-18Buy1,200,000$2.559.2 view
Patterson Scott Bradford10% Owner 2012-06-28Buy44,824$5.14-22.57 view
Patterson Scott Bradford10% Owner 2012-06-25Buy27,462$5-20.4 view

Press Releases about CYTR :

    Quarterly/Annual Reports about CYTR:

    News about CYTR:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
    Weekly CEO Buys Highlight: ULBI, BDE, ALNY, CTTR, GFN Feb 27 2012 
    Weekly CFO Buys Highlight: CYTR, PZZI, AGYS, PLBC Feb 27 2012 
    CytRx Corp. Reports Operating Results (10-K) Mar 11 2011 
    CytRx Corp. Reports Operating Results (10-Q) Nov 08 2010 
    CytRx Corp. Reports Operating Results (10-Q) Aug 09 2010 
    CytRx Corp. Reports Operating Results (10-Q) May 06 2010 
    CytRx Corp. Reports Operating Results (10-Q) Nov 09 2009 
    CytRx Reports 2009 Second Quarter Financial Results Aug 10 2009 
    CytRx Corp. Reports Operating Results (10-Q) Aug 07 2009 

    More From Other Websites
    CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting May 27 2015
    CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting May 27 2015
    CytRx to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
    CytRx to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
    Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape May 22 2015
    CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma... May 21 2015
    CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma... May 21 2015
    10-K for CytRx Corp. May 07 2015
    This Is A Near-Term Driver At CytRX May 05 2015
    CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in... May 04 2015
    CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in... May 04 2015
    10-Q for CytRx Corp. May 03 2015
    CytRx Reports First Quarter 2015 Financial Results May 01 2015
    CytRx reports 1Q loss May 01 2015
    CytRx reports 1Q loss May 01 2015
    CytRx Reports First Quarter 2015 Financial Results May 01 2015
    CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or... May 01 2015
    CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine &... Apr 29 2015
    CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine &... Apr 29 2015
    GenSpera Looks Undervalued Compared to Its Peers Apr 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK